🇺🇸 Atorvastatin (generic Lipitor) in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 11

Most-reported reactions

1. Hypoaesthesia — 2 reports (18.18%)
2. Back Pain — 1 report (9.09%)
3. Chills — 1 report (9.09%)
4. Dysgeusia — 1 report (9.09%)
5. Dysstasia — 1 report (9.09%)
6. Feeling Abnormal — 1 report (9.09%)
7. Feeling Cold — 1 report (9.09%)
8. Gingival Swelling — 1 report (9.09%)
9. High Density Lipoprotein Decreased — 1 report (9.09%)
10. Middle Insomnia — 1 report (9.09%)

Source database →

Frequently asked questions

Is Atorvastatin (generic Lipitor) approved in United States?

Atorvastatin (generic Lipitor) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Atorvastatin (generic Lipitor) in United States?

University of Pennsylvania is the originator. The local marketing authorisation holder may differ — check the official source linked above.